LOS ANGELES -- The FDA's warning about arrhythmia risk with lamotrigine (Lamictal) based on in vitro data wasn't borne out in observational cohorts of people with epilepsy, although the risk did ...
One lot of epilepsy and bipolar disorder tablets got recalled Friday after someone discovered a cross-contamination with a drug used in heart and blood pressure medication, according to the FDA-posted ...
The FDA on Wednesday updated its warning about potential increased arrhythmia risk in people with cardiac disease who are taking the seizure and mental health drug lamotrigine (Lamictal) with new data ...
Lamotrigine is indicated as monotherapy or adjunctive therapy for epilepsy and for use as maintenance treatment in patients with bipolar I disorder. Following a review of in vitro study findings, the ...
Everyday Health on MSN
How to reduce the most common side effects of bipolar medications without stopping treatment
Learn to manage bipolar medication side effects such as weight gain, drowsiness, and brain fog with lifestyle changes and ...
A new study found that the drug lamotrigine, used to treat epilepsy and stabilize mood in people with bipolar disorder, worked to stop behaviors like hyperactivity that are linked to autism in mice, ...
LISLE, IL, UNITED STATES, January 12, 2026 /EINPresswire.com/ -- OWP Pharmaceuticals today announced commercial product ...
Researchers found that the mean interactive voice response stiffness score after treatment with mexiletine was 2.54 vs 2.77 with lamotrigine. HealthDay News — Improvements in nondystrophic myotonias ...
Everyday Health on MSN
Morning vs. evening dosing: When you take bipolar meds might matter more than you think
Explore the importance of timing when taking bipolar medications to maximize effectiveness and minimize side effects. Learn why morning or evening dosing matters for optimal treatment.
Please provide your email address to receive an email when new articles are posted on . The FDA has granted approval to Amring Pharmaceuticals Inc. for its generic lamotrigine ODT, according to a ...
September 6, 2006 — The US Food and Drug Administration (FDA) has approved first-time generic formulations for ciprofloxacin 200-mg/20-mL, 400-mg/40-mL, and 1200-mg/20-mL single-dose vials in the ...
It's one of the most missed diagnoses in psychiatry. Bipolar disorder, involving moods that swing between the highs of mania and the lows of depression, is typically confused with everything from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results